Connecticut is the latest state to join the efforts of jurisdictions such as Oregon, Nevada, Washington D.C., and the City of Chicago, Illinois, in further regulating the activities of pharmaceutical representatives. In June,...more
10/26/2023
/ Connecticut ,
Disclosure Requirements ,
Governor Lamont ,
Healthcare Reform ,
Legislative Agendas ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Reporting Requirements ,
State and Local Government ,
State Legislatures